Laurilee Kearnes - May 2, 2025 Form 4/A - Amendment Insider Report for Byrna Technologies Inc. (BYRN)

Role
Chief Financial Officer
Signature
/s/ Lisa Klein Wager by Power of Attorney
Stock symbol
BYRN
Transactions as of
May 2, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/12/2025, 06:01 AM
Date Of Original Report
May 8, 2025
Previous filing
Nov 18, 2024
Next filing
Jun 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KEARNES LAURILEE Chief Financial Officer 100 BURTT ROAD, SUITE 115, ANDOVER /s/ Lisa Klein Wager by Power of Attorney 2025-05-09 0001751130

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BYRN Restricted Stock Unit Award $0 +6.94K $0.00 6.94K May 2, 2025 Common Stock 6.94K Direct F1, F2
transaction BYRN Restricted Stock Unit Award $0 +6.94K $0.00 6.94K May 2, 2025 Common Stock 6.94K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the common stock of Byrna Technologies Inc.
F2 The restricted stock units vest in three equal tranches on May 2, 2026, March 1, 2027 and March 1, 2028, provided that such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction. This amendment corrects the vesting dates of the second and third RSU tranches to comport to the terms of the grant.
F3 The restricted stock units are performance-based and will vest on November 30, 2027 if and to the extent that (a) the issuer achieves preset revenue levels for its fiscal year ending November 30, 2026 and (b) the reporting person (i) remains employed by the issuer through November 30, 2027 or (ii) is terminated without cause after November 30, 2026. Such vesting will be accelerated upon the death or disability of the reporting person or upon the termination of the reporting person without cause or resignation by the reporting person for good reason within 12 months following a qualifying change of control transaction.